journal article·2023-10

Type-I organic photosensitizers with two complementary reactive oxygen species based on donor-acceptor (D-A) molecules

Wen Wang, Yanyan Liu, Haiyang Wang, Faxu Lin, Huahua Huang, Zuanguang Chen, Zhiyong Yang, Zhenguo Chi, Xie Zhou

Dyes and Pigments· Volume 218
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (35)

Show source-provided references
1. Good steel used in the blade: well-tailored type-I photosensitizers with aggregation-induced emission characteristics for precise nuclear targeting photodynamic therapy10.1002/advs.202100524 ↗
2. Cancer-cell-activated in situ synthesis of mitochondria-targeting AIE photosensitizer for precise photodynamic therapy10.1002/anie.202017350 ↗
3. The concept and examples of type-III photosensitizers for cancer photodynamic therapy10.1016/j.chempr.2021.10.006 ↗
4. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application10.1039/D0CS00173B ↗
5. How does photodynamic therapy work?10.1111/j.1751-1097.1992.tb04222.x ↗
6. Photodynamic therapy and anti-tumour immunity10.1038/nrc1894 ↗
7. Photophysics and photochemistry of photodynamic therapy: fundamental aspects10.1007/s10103-008-0539-1 ↗
8. Cell death pathways in photodynamic therapy of cancer10.3390/cancers3022516 ↗
9. Reactive oxygen species (ROS)-Based nanomedicine10.1021/acs.chemrev.8b00626 ↗
10. A feasible strategy of fabricating type I photosensitizer for photodynamic therapy in cancer cells and pathogens10.1021/acsnano.1c01577 ↗
11. Unimolecular photodynamic O2-economizer to overcome hypoxia resistance in phototherapeutics10.1021/jacs.0c00734 ↗
12. Design of pluronic-based formulation for enhanced redaporfin-photodynamic therapy against pigmented melanoma10.1021/acsami.6b07031 ↗
13. Upconversion nanoparticle-induced multimode photodynamic therapy based on a metal-organic framework/titanium dioxide nanocomposite10.1021/acsami.0c01467 ↗
14. Cascade reactions by nitric oxide and hydrogen radical for anti-hypoxia photodynamic therapy using an activatable photosensitizer10.1021/jacs.0c10517 ↗
15. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
16. Endoplasmic reticulum-localized iridium(III) complexes as efficient photodynamic therapy agents via protein modifications10.1021/jacs.6b05302 ↗
17. Restricting bond rotations by ring fusion: a novel molecular design strategy to improve photodynamic antibacterial efficacy of AIE photosensitizers10.1021/acsami.1c24329 ↗
18. Long-wavelength AIE-based fluorescent probes for mitochondria-targeted imaging and photodynamic therapy of hepatoma cells10.1021/acsabm.1c00673 ↗
19. Metabolic competition in the tumor microenvironment is a driver of cancer progression10.1016/j.cell.2015.08.016 ↗
20. Chemical design and synthesis of functionalized probes for imaging and treating tumor hypoxia10.1021/acs.chemrev.6b00525 ↗
21. Near-infrared upconversion mesoporous cerium oxide hollow biophotocatalyst for concurrent pH-/H2O2 -responsive O2 -evolving synergetic cancer therapy10.1002/adma.201704833 ↗
22. Superoxide radical photogenerator with amplification effect: surmounting the achilles' heels of photodynamic oncotherapy10.1021/jacs.8b13141 ↗
23. Molecular engineering to boost AIE‐active free radical photogenerators and enable high‐performance photodynamic therapy under hypoxia10.1002/adfm.202002057 ↗
24. Precise molecular engineering of type I photosensitizers with near-infrared aggregation-induced emission for image-guided photodynamic killing of multidrug-resistant bacteria10.1002/advs.202104079 ↗
25. Type I photosensitizers revitalizing photodynamic oncotherapy
26. Aggregation‐enhanced theranostics: AIE sparkles in biomedical field10.1002/agt2.7 ↗
27. Precise and long-term tracking of adipose-derived stem cells and their regenerative capacity via superb bright and stable organic nanodots10.1021/nn505554y ↗
28. Long wavelength excitable near-infrared fluorescent nanoparticles with aggregation-induced emission characteristics for image-guided tumor resection10.1039/C6SC04384D ↗
29. Aggregation-induced emission (AIE) dots: emerging theranostic nanolights10.1021/acs.accounts.8b00060 ↗
30. 9,10-Phenanthrenequinone: a promising kernel to develop multifunctional antitumor systems for efficient type I photodynamic and photothermal synergistic therapy10.1021/acsnano.1c07730 ↗
31. A highly efficient and photostable photosensitizer with near-infrared aggregation-induced emission for image-guided photodynamic anticancer therapy10.1002/adma.201700548 ↗
32. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect10.1016/j.addr.2010.04.009 ↗
33. Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?10.7150/thno.7193 ↗
34. O2-Generating MnO2 nanoparticles for enhanced photodynamic therapy of bladder cancer by ameliorating hypoxia10.7150/thno.22465 ↗
35. An NIR-II-emissive photosensitizer for hypoxia-tolerant photodynamic theranostics10.1002/adma.202003471 ↗